Jade Biosciences, Inc. Accounts Payable
Jade Biosciences, Inc. (JBIO) had Accounts Payable of $6.58 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2026-08-10
- 2026-06-30: Accounts Payable, Current $6.58M.
- 2026-03-31: Accounts Payable, Current $3.98M.
- 2025-12-31: Accounts Payable, Current $2.15M.
- 2025-09-30: Accounts Payable, Current $1.35M.
| Period end | Accounts Payable, Current | Accounts Payable, Current as first filed |
|---|---|---|
| 2026-06-30 | $6.58M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $3.98M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $2.15M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $1.35M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $7.59M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $69.00K 10-Q · filed 2025-04-25 | |
| 2024-12-31 | $1.29M 10-K · filed 2026-03-06 | $224.00K 10-K · filed 2025-03-27 |
| 2024-09-30 | $908.00K 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $4.18M 10-Q · filed 2024-08-12 | |
| 2024-03-31 | $3.31M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $2.40M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $3.50M 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $5.53M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $4.73M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $2.58M 10-K · filed 2024-03-25 | |
| 2022-09-30 | $4.54M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $2.07M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $2.86M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $1.21M 10-K · filed 2023-03-29 | |
| 2021-09-30 | $2.56M 10-Q · filed 2021-11-15 | |
| 2020-12-31 | $618.00K 10-K · filed 2022-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 | |
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |